A Rollover Study of CC-122
Bristol-Myers Squibb
Bristol-Myers Squibb
Sutro Biopharma, Inc.
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Merck Sharp & Dohme LLC
Barbara Ann Karmanos Cancer Institute
Incuron
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
University of Maryland, Baltimore
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Swiss Cancer Institute
University of California, Davis
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
California Cancer Consortium
Massachusetts General Hospital
University of Louisville
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Virginia Commonwealth University
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Cellerant Therapeutics
Indiana University
Indiana University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)